The irreversible ERBB1/2/4 inhibitor neratinib interacts...

  • Main
  • 2018 / 01
  • The irreversible ERBB1/2/4 inhibitor neratinib interacts...
Cancer Biology & Therapy 2018 / 01

The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells.

Booth, Laurence, Roberts, Jane L., Avogadri-Connors, Francesca, CutlerJr, Richard E., Lalani, Alshad S., Poklepovic, Andrew, Dent, Paul
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.1080/15384047.2018.1423927
Date:
January, 2018
File:
PDF, 1.60 MB
english, 2018
Conversion to is in progress
Conversion to is failed